Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,102
Closed -$266K 304
2023
Q1
$266K Buy
+1,102
New +$271K 0.04% 243
2022
Q2
$333K Sell
1,369
-1,744
-56% -$427K 0.09% 128
2022
Q1
$753K Buy
+3,113
New +$715K 0.12% 115
2021
Q3
Sell
-1,150
Closed -$280K 186
2021
Q2
$280K Buy
1,150
+21
+2% +$5.17K 0.06% 151
2021
Q1
$281K Buy
1,129
+15
+1% +$3.58K 0.08% 151
2020
Q4
$256K Sell
1,114
-130
-10% -$30K 0.08% 145
2020
Q3
$293K Buy
+1,244
New +$308K 0.12% 97

Other funds holding AMGN

Leo Brokerage's AMGN Position: Q2 2023 in Review

Leo Brokerage sold out of Amgen (AMGN) in Q2 2023, closing a stake of 1,102 shares — an estimated $266K sold.

Leo Brokerage first reported a position in AMGN in Q3 2020 and held it in 7 quarters. The position peaked at $753K in Q1 2022. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Leo Brokerage reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Leo Brokerage sold 1,102 Amgen shares in Q2 2023, an estimated $266K.
  • Leo Brokerage first reported a position in Amgen in Q3 2020 and held it in 7 quarters.
  • Leo Brokerage's Amgen position peaked at $753K in Q1 2022.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.